Clinical Trials Browser

Colorectal Adenocarcinoma × Nivolumab × 90 days × Clear all

NCT04457284 2026-03-13

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Adenocarcinoma